Bioscience

Arizona Bioscience News: ASU discovers potential norovirus vaccine; TGen continues CTE study; Clinical Research Fastrack offers career assistance

August 23, 2018

By Chris Farrington

Tempe startup puts clinical research training on fast track / Phoenix Business Journal

Clinical Research Fastrack taps into the $100 billion clinical research industry by condensing a year-long college course to four weeks and including an internship at some of the largest companies in the nation to help fill open positions in clinical research.

Study underway to help diagnose CTE earlier Fox 10

Researchers and doctors at Translational Genomics Research Institute in Phoenix are hoping to detect CTE, a brain disease associated with head trauma that affects athletes and veterans with a history of concussions, before the symptoms start showing.

ASU closer to reopening former TechShop space Phoenix Business Journal

Arizona State University officials are waiting for a bankruptcy judge to approve an agreement that will allow ASU to take over the popular do-it-yourself maker space in Chandler formerly owned by TechShop and some of the millions of dollars in equipment.

ASU researchers discover vaccine for norovirus using tobacco plant / ABC 15

Arizona State University’s Biodesign Institute researchers say a form of the tobacco plant may be the key to a vaccine against the highly contagious and deadly norovirus stomach bug.

Researchers work to improve Parkinson’s disease treatment / Daily Wildcat

Two researchers at the University of Arizona College of Medicine – Tucson recently received a three-year, $750,000 grant from the Arizona Biomedical Research Commission to study how ketamine might be used to improve the lives of patients with Parkinson’s disease.